DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @AmericanBanking | 12 |
| @Tickeron | 10 |
| @TheMarketsDaily | 8 |
| @ConsumerFeed | 8 |
| @WeekHerald | 7 |
Recent Tweets for FATE
 |
@gcassidy718 $FATE considerable price movement 4.18 % change recently https://t.co/rJRHk0DOAl November 17th 2019, 4:11am |
 |
@ConsumerFeed Fate Therapeutics $FATE Rating Lowered to Buy at ValuEngine https://t.co/oThMSlsCdJ November 17th 2019, 2:11am |
 |
@OlympiaReport Fate Therapeutics $FATE Coverage Initiated at SunTrust Banks https://t.co/MHd5YRZmpE November 16th 2019, 8:11pm |
 |
@TickerReport Fate Therapeutics $FATE Receives New Coverage from Analysts at SunTrust Banks https://t.co/g7f3bii6Fc November 16th 2019, 8:11pm |
 |
@WatchlistN Fate Therapeutics $FATE Receives New Coverage from Analysts at SunTrust Banks https://t.co/E3pmzVpfFH November 16th 2019, 8:11pm |
 |
@TheMarketsDaily Fate Therapeutics $FATE Stock Rating Lowered by ValuEngine https://t.co/51ZtSC1OaA November 16th 2019, 4:11pm |
 |
@Gambiste1 RT @IlliniJJ: $FATE - good to see On November 13, 2019, Fate Therapeutics repaid in full all outstanding obligations under the Loan Agreem… November 15th 2019, 10:11pm |
 |
@Tickeron $FATE in Uptrend: price expected to rise as it breaks its lower Bollinger Band on November 6, 2019. View odds for t… https://t.co/Tvb7OHLtDI November 15th 2019, 7:11pm |
 |
@BlueBioNow $FATE substantial stock price changes 3.26 % change recently https://t.co/BXYgVAHbXB November 15th 2019, 3:11pm |
 |
@1stOncology #FateTherapeutics to Present at the Jefferies 2019 London #HealthcareConference $FATE https://t.co/SIrMS2acAt November 15th 2019, 6:11am |
 |
@dhovekamp42 RT @otcdynamics: $FATE Fate Therapeutics to Present at the Jefferies 2019 London Healthcare Conference https://t.co/msJUtUgJB6 November 15th 2019, 2:11am |
 |
@IlliniJJ $FATE - good to see On November 13, 2019, Fate Therapeutics repaid in full all outstanding obligations under the L… https://t.co/LJf2GfEgkG November 14th 2019, 8:11pm |
|
@BlueBioNow $FATE I’ll probably buy on the dip. Still need to do more research. -4.45 % https://t.co/BXYgVApB63 November 14th 2019, 7:11pm |
 |
@otcdynamics $FATE Fate Therapeutics to Present at the Jefferies 2019 London Healthcare Conference https://t.co/msJUtUgJB6 November 14th 2019, 4:11pm |
|
@Tickeron $FATE in Downtrend: Stochastic indicator leaves overbought zone. View odds for this and other indicators:… https://t.co/veY36rw1xe November 13th 2019, 6:11pm |
|
@BlueBioNow $FATE definitely going to finish over $16.65 4.38 % change recently https://t.co/BXYgVAHbXB November 12th 2019, 2:11pm |
 |
@WeekHerald Fate Therapeutics $FATE Research Coverage Started at SunTrust Banks https://t.co/7hhWkW1PPb November 12th 2019, 10:11am |
 |
@ThisLincolnian Fate Therapeutics $FATE Research Coverage Started at SunTrust Banks https://t.co/YgGWeoRkNM November 12th 2019, 10:11am |
 |
@AmericanBanking Fate Therapeutics $FATE Research Coverage Started at SunTrust Banks https://t.co/rItvC3erNi #stocks November 12th 2019, 9:11am |
|
@dhovekamp42 RT @Quantumup1: $FATE initiated with a Buy rating, $25 PT at SunTrust https://t.co/7asnIOIe3P November 12th 2019, 8:11am |
 |
@Quantumup1 $FATE initiated with a Buy rating, $25 PT at SunTrust https://t.co/7asnIOIe3P November 12th 2019, 8:11am |
|
@dhovekamp42 RT @stockhoot: $FATE SunTrust Robinson Humphrey Initiates Coverage On to Buy : PT $25.00 https://t.co/609DW5cERr November 12th 2019, 7:11am |
 |
@stockhoot $FATE SunTrust Robinson Humphrey Initiates Coverage On to Buy : PT $25.00 https://t.co/609DW5cERr November 12th 2019, 6:11am |
 |
@MrKenn14 SunTrust Robinson Humphrey Initiates Coverage On Fate Therapeutics with Buy Rating, Announces $25 Price Target $FATE November 12th 2019, 6:11am |
 |
@dakotafinancial Wedbush Analysts Raise Earnings Estimates for Fate Therapeutics Inc $FATE https://t.co/nUnVtRkctT November 12th 2019, 2:11am |
 |
@OnlyBios 2) There’s $FATE which raises when their stock price is high. They raised once below $3 but that’s when they needed… https://t.co/Fs8a2rC8Qg November 11th 2019, 7:11pm |
|
@Tickeron $FATE in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/iv4m0xkAIj November 11th 2019, 6:11pm |
 |
@TranscriptDaily Wedbush Brokers Boost Earnings Estimates for Fate Therapeutics Inc $FATE https://t.co/CzngEaf5MD November 11th 2019, 3:11am |
|
@TheMarketsDaily Fate Therapeutics Inc to Post FY2019 Earnings of -$1.48 Per Share, Svb Leerink Forecasts $FATE https://t.co/hLcOIQjHrN November 11th 2019, 3:11am |
 |
@EnterpriseLeade FY2019 Earnings Estimate for Fate Therapeutics Inc Issued By Wedbush $FATE https://t.co/ibTkzy22Vt November 11th 2019, 3:11am |
 |
@stocknewstimes Fate Therapeutics Inc to Post FY2019 Earnings of -$1.48 Per Share, Svb Leerink Forecasts $FATE https://t.co/9qkI1swkMb November 11th 2019, 3:11am |
|
@dakotafinancial Fate Therapeutics $FATE Lowered to Hold at Zacks Investment Research https://t.co/lyuaSykmIO November 11th 2019, 12:11am |
|
@ConsumerFeed Fate Therapeutics $FATE Downgraded to Hold at Zacks Investment Research https://t.co/uysy2HE1eI November 11th 2019, 12:11am |
 |
@dispatchtribune Fate Therapeutics Inc $FATE Expected to Announce Quarterly Sales of $1.81 Million https://t.co/MM5KpW4EGV November 10th 2019, 8:11pm |
|
@EnterpriseLeade $1.81 Million in Sales Expected for Fate Therapeutics Inc $FATE This Quarter https://t.co/ZM1AMBdBxB November 10th 2019, 8:11pm |
|
@dakotafinancial Zacks: Brokerages Anticipate Fate Therapeutics Inc $FATE Will Post Earnings of -$0.39 Per Share https://t.co/tBLhcTON18 November 10th 2019, 7:11pm |
|
@Tickeron $FATE in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/spyhZtTjZT November 10th 2019, 6:11pm |
|
@WeekHerald Fate Therapeutics $FATE Stock Rating Lowered by Wells Fargo & Co https://t.co/MW9wqWxhYu November 10th 2019, 2:11pm |
|
@dispatchtribune Fate Therapeutics $FATE Stock Rating Lowered by Mizuho https://t.co/Y59D6gbiRx November 10th 2019, 12:11pm |
|
@EnterpriseLeade Fate Therapeutics $FATE Stock Rating Lowered by Mizuho https://t.co/8uVK711w3f November 10th 2019, 12:11pm |
|
@dakotafinancial BMO Capital Markets Lowers Fate Therapeutics $FATE Price Target to $26.00 https://t.co/pr0DgFOB7a November 10th 2019, 11:11am |
|
@OlympiaReport Piper Jaffray Companies Comments on Fate Therapeutics Inc’s FY2019 Earnings $FATE https://t.co/unAy80QKYW November 10th 2019, 6:11am |
|
@ConsumerFeed FY2019 Earnings Forecast for Fate Therapeutics Inc Issued By Jefferies Financial Group $FATE https://t.co/6m5WTsivdn November 10th 2019, 6:11am |
|
@TranscriptDaily FY2019 Earnings Forecast for Fate Therapeutics Inc $FATE Issued By Oppenheimer https://t.co/P1raAAUD26 November 10th 2019, 6:11am |
|
@ThisLincolnian Fate Therapeutics Inc to Post FY2019 Earnings of -$1.48 Per Share, Cantor Fitzgerald Forecasts $FATE https://t.co/OJnYs9VnaW November 10th 2019, 6:11am |
|
@stocknewstimes FY2019 Earnings Forecast for Fate Therapeutics Inc $FATE Issued By Oppenheimer https://t.co/VLh2Txf67p November 10th 2019, 6:11am |
 |
@newsfilterio Fate Therapeutics Announces Six Presentations at the 2019 ASH Annual Meeting $FATE https://t.co/44cxnlaZsV November 10th 2019, 4:11am |
|
@AmericanBanking Fate Therapeutics Inc $FATE Given Average Rating of “Buy” by Brokerages https://t.co/o2yZD1Q0Oe #stocks November 10th 2019, 1:11am |
 |
@dailypoliticaln Fate Therapeutics Inc $FATE Receives Average Recommendation of “Buy” from Analysts https://t.co/7elqZYhkca November 10th 2019, 1:11am |
|
@TickerReport Fate Therapeutics Inc $FATE Given Average Rating of “Buy” by Brokerages https://t.co/px6eFtnJkP November 10th 2019, 1:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.